- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
Wednesday, May 18, 2016
We know that an HIV vaccine will be an important part of a long-term strategy to end the HIV/AIDS epidemic. The road ahead is long, but an HIV vaccine is possible. Clinical trials—even those with disappointing results—and early-stage research provide critical clues to the way forward. This graphic is excerpted from HIV Vaccines by the Numbers: Trials, discoveries, money and more.